|
I.A. Kurnikova
Diabetic neuropathy: pathophysiological mechanisms and metabolic therapy
|
№12 / 2023
|
|
O.L. Badalyan, A.A. Savenkov
PATHOGENETIC THERAPY OF DIABETIC POLYNEUROPATHY
|
№5 / 2016
|
|
T.A. Meleshkevich (1, 2), E.I. Luchina (1), M.E. Lukashova (1)
THE USE OF ACTOVEGIN AS A UNIVERSAL METHOD FOR THE TREATMENT OF DIABETES COMPLICATIONS
|
№18 / 2014
|
|
D.A. Gusakova, E.A. Efremov
PATHOGENETIC APPROACH TO THE USE OF ALPHA-LIPOIC ACID IN THE TREATMENT OF ERECTILE DYSFUNCTION IN PATIENTS WITH DIABETES MELLITUS
|
№12 / 2014
|
|
A.S. Ametov, MD, Professor, M.A. Lysenko
Neuropathy And Prediabetes: This Clock Starts Ticking Early
|
№16 / 2012
|
|
S.V. Podachina
Role Of Glycation End-products Blockers In The Development Of Neurologic Complications Of Diabetes Mellitus
|
№16 / 2011
|
|
I.V. Gur’eva
Therapeutic Potentials Of Benfotiamine
|
№16 / 2010
|
|
Y. Akarachkova
Milgamma In Neurological Practice
|
№10 / 2010
|
|
E.S. Akarachkova
Milgamma Compositum In The Therapy Of Neuropathic Pain
|
№15 / 2009
|
|
V.V. Dengin С. 3236
New Directions Of Drugs Milgamma And Milgamma Compositum Use In The Diabetes Mellitus
|
№10 / 2009
|
Русский
